Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$922M |
| 2 |
EOG Resources
EOG
|
$517M |
| 3 |
Mastercard
MA
|
$436M |
| 4 |
Las Vegas Sands
LVS
|
$385M |
| 5 |
Booking.com
BKNG
|
$382M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$660M |
| 2 |
Morgan Stanley
MS
|
$519M |
| 3 |
PayPal
PYPL
|
$479M |
| 4 |
Meta Platforms (Facebook)
META
|
$478M |
| 5 |
Pfizer
PFE
|
$405M |
Sector Composition
| 1 | Technology | 24.82% |
| 2 | Financials | 12.45% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CINC
3101
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $284K | ﹤0.01% |
+16,179
| New | +$284K |
|
|
ICAD
3102
DELISTED
iCAD Inc
ICAD
| $278K | ﹤0.01% |
68,869
| – | – |
|
|
TBHC
3103
The Brand House Collective, Inc. Common Stock
TBHC
$38.6M
| $278K | ﹤0.01% |
24,921
-8,236
| -25% | -$91.9K |
|
3104
IBEX
IBEX
$393M
| $277K | ﹤0.01% |
17,362
-7,637
| -31% | -$122K |
|
3105
Verrica Pharmaceuticals
VRCA
$48.3M
| $277K | ﹤0.01% |
3,279
| – | – |
|
3106
American Coastal Insurance
ACIC
$554M
| $275K | ﹤0.01% |
77,754
+1,538
| +2% | +$5.44K |
|
3107
ARS Pharmaceuticals
SPRY
$995M
| $272K | ﹤0.01% |
64,723
+1,433
| +2% | +$6.02K |
|
|
PNT
3108
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $271K | ﹤0.01% |
+41,817
| New | +$271K |
|
3109
Black Diamond Therapeutics
BDTX
$167M
| $268K | ﹤0.01% |
86,043
+1,996
| +2% | +$6.22K |
|
|
LX
3110
LexinFintech Holdings
LX
$1.02B
| $268K | ﹤0.01% |
102,200
-7,600
| -7% | -$19.9K |
|
|
EH
3111
EHang Holdings
EH
$1.16B
| $267K | ﹤0.01% |
22,300
-1,700
| -7% | -$20.4K |
|
3112
Soho House & Co
SHCO
$1.72B
| $266K | ﹤0.01% |
+34,499
| New | +$266K |
|
3113
Solid Biosciences
SLDB
$428M
| $266K | ﹤0.01% |
13,877
-26,907
| -66% | -$516K |
|
3114
Neuronetics
STIM
$214M
| $264K | ﹤0.01% |
79,147
+11
| +0% | +$37 |
|
3115
Western Midstream Partners
WES
$14.5B
| $263K | ﹤0.01% |
+10,724
| New | +$263K |
|
3116
Zymeworks
ZYME
$1.14B
| $254K | ﹤0.01% |
36,322
+3,008
| +9% | +$21K |
|
|
DAO
3117
Youdao
DAO
$1.04B
| $252K | ﹤0.01% |
35,500
-2,800
| -7% | -$19.9K |
|
3118
Neurogene
NGNE
$285M
| $252K | ﹤0.01% |
6,533
+74
| +1% | +$2.85K |
|
|
TRVN
3119
DELISTED
Trevena, Inc.
TRVN
| $251K | ﹤0.01% |
823
| – | – |
|
3120
KALA BIO
KALA
$102M
| $250K | ﹤0.01% |
3,246
+20
| +0.6% | +$1.54K |
|
3121
The Beachbody Company, Inc. Class A Common Stock
BODI
$40.8M
| $247K | ﹤0.01% |
+2,263
| New | +$247K |
|
|
UXIN
3122
Uxin Ltd
UXIN
$722M
| $244K | ﹤0.01% |
2,393
-189
| -7% | -$19.3K |
|
3123
Fortress Biotech
FBIO
$110M
| $243K | ﹤0.01% |
11,438
+34
| +0.3% | +$722 |
|
3124
1stdibs.com
DIBS
$100M
| $243K | ﹤0.01% |
+28,633
| New | +$243K |
|
|
PLM
3125
DELISTED
PolyMet Mining Corp.
PLM
| $239K | ﹤0.01% |
69,197
-125
| -0.2% | -$432 |
|